Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant Opens in a new window
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant Opens in a new window
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
    • Charitable Giving
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant Opens in a new window
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant Opens in a new window
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

Beatrice Society Forms Board of Directors

BY Business Wire
— 8:00 AM ET 11/22/2021

Gary Yeoman to Serve as Chairman

TORONTO--(BUSINESS WIRE)-- Beatrice Society (“The Company” or “Beatrice”), a psychedelics and functional mushroom company focused on improving psychotherapy-driven patient outcomes and everyday quality of life, today announced the formation of its initial Board of Directors, including a new Chairman. The Board is currently comprised of three seasoned professionals, including:

  • Gary Yeoman, Chairman
  • Lorne Gertner, Director
  • Krisztián Tóth, Director

“We are pleased to welcome Gary Yeoman as Chairman, alongside highly qualified directors to Beatrice Society,” said John Baker, CEO of Beatrice Society. “Each director provides the company with valuable perspective and brings with them a wealth of experience. This fantastic slate of industry veterans will provide a solid foundation for building upon the successes of Beatrice’s latest acquisitions in the psychedelics and wellness space.”

Gary Yeoman
Mr. Yeoman currently serves as Executive Chairman at Voxtur Analytics Inc. In 2013, he joined ILA (now Voxtur Analytics Corp.) as Chairman and was appointed CEO in 2017. Prior to this role, he founded and served as CEO of Altus Group (ASGTF) , a leading provider of software, data solutions and independent advisory services to the global commercial real estate industry. Mr. Yeoman led Altus through an IPO in 2005 and a 7-year growth period during which the company realized a 333% increase in revenues from $75M to approximately $325M.

Lorne Gertner
Lorne is a co-founder and board member of GoodCap Pharmaceuticals Inc. His prior experience in drug development includes co-founding Cannasat Therapeutics, which sold to Sunovion Pharmaceuticals Inc. in 2016 for C$841 million. As a pioneer within Canada’s nascent cannabis industry, Mr. Gertner co-founded and served as Chairman of PharmaCan Capital Corporation, now Cronos Group Inc (CRON) . He is also the co-founder of Tokyo Smoke, an industry-leading cannabis retailer purchased by Canopy Growth (CGC) in 2018.

Krisztián Tóth
Mr. Tóth currently serves as Partner at Fasken Martineau DuMoulin LLP. His practice focuses on mergers and acquisitions and corporate finance with an emphasis on cross-border transactions, proxy contests and other contested matters, public and private financings, securities regulations and corporate governance.

About Beatrice Society
Beatrice Society Inc. exists to fuel the growing psychedelic therapy industry through public and professional education and therapies.

Beatrice’s consumer-oriented brand drives public awareness of psychedelic therapies through credible editorial content focused on answering common questions, and quality functional mushroom products that serve as an approachable introduction to the category.

Beatrice supports the mental health industry by equipping clinicians with patient-centred, evidence-based protocols for psychedelic-assisted psychotherapy treatment. Training existing clinicians in their proprietary TRIP™ protocol will help to alleviate the shortage of mental healthcare practitioners trained in psychedelic therapy, while their growing network of clinics allows for expedited expansion with consistency in both therapeutic process and post-integration analysis.

To learn more visit beatricesociety.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122005259/en/

Source: Beatrice Society Inc.

More CRON News

  • Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter
    GlobeNewswire - 4:30 PM ET 11/19/2021
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close